Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBITDA Margin (2016 - 2018)

Historic EBITDA Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to 326.71%.

  • Armata Pharmaceuticals' EBITDA Margin rose 121517100.0% to 326.71% in Q4 2018 from the same period last year, while for Dec 2018 it was 1015.89%, marking a year-over-year increase of 150645900.0%. This contributed to the annual value of 762.14% for FY2024, which is 29108500.0% up from last year.
  • Per Armata Pharmaceuticals' latest filing, its EBITDA Margin stood at 326.71% for Q4 2018, which was up 121517100.0% from 902.61% recorded in Q3 2018.
  • Armata Pharmaceuticals' EBITDA Margin's 5-year high stood at 18733.01% during Q3 2014, with a 5-year trough of 53927.27% in Q4 2016.
  • For the 5-year period, Armata Pharmaceuticals' EBITDA Margin averaged around 6313.92%, with its median value being 2541.18% (2015).
  • Per our database at Business Quant, Armata Pharmaceuticals' EBITDA Margin surged by 2000000000bps in 2014 and then crashed by -516304000bps in 2016.
  • Armata Pharmaceuticals' EBITDA Margin (Quarter) stood at 2571.29% in 2014, then grew by 11bps to 2296.88% in 2015, then tumbled by -2248bps to 53927.27% in 2016, then skyrocketed by 78bps to 11825.0% in 2017, then soared by 103bps to 326.71% in 2018.
  • Its EBITDA Margin stands at 326.71% for Q4 2018, versus 902.61% for Q3 2018 and 1124.56% for Q2 2018.